APA (7th ed.) Citation

LR, N., JL, O., & CE, M. (2025). Beyond relapses: How BTK inhibitors are shaping the future of progressive MS treatment. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 22(4), e00602. https://doi.org/10.1016/j.neurot.2025.e00602

Chicago Style (17th ed.) Citation

LR, Naydovich, Orthmann-Murphy JL, and Markowitz CE. "Beyond Relapses: How BTK Inhibitors Are Shaping the Future of Progressive MS Treatment." Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics 22, no. 4 (2025): e00602. https://doi.org/10.1016/j.neurot.2025.e00602.

MLA (9th ed.) Citation

LR, Naydovich, et al. "Beyond Relapses: How BTK Inhibitors Are Shaping the Future of Progressive MS Treatment." Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics, vol. 22, no. 4, 2025, p. e00602, https://doi.org/10.1016/j.neurot.2025.e00602.